144 related articles for article (PubMed ID: 23952052)
1. Q10-triggered facial vitiligo.
Schallreuter KU
Br J Dermatol; 2013 Dec; 169(6):1333-6. PubMed ID: 23952052
[TBL] [Abstract][Full Text] [Related]
2. Basic evidence for epidermal H2O2/ONOO(-)-mediated oxidation/nitration in segmental vitiligo is supported by repigmentation of skin and eyelashes after reduction of epidermal H2O2 with topical NB-UVB-activated pseudocatalase PC-KUS.
Schallreuter KU; Salem MA; Holtz S; Panske A
FASEB J; 2013 Aug; 27(8):3113-22. PubMed ID: 23629861
[TBL] [Abstract][Full Text] [Related]
3. Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS).
Schallreuter KU; Moore J; Behrens-Williams S; Panske A; Harari M
Int J Dermatol; 2002 Aug; 41(8):482-7. PubMed ID: 12207762
[TBL] [Abstract][Full Text] [Related]
4. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo.
Schallreuter KU; Krüger C; Würfel BA; Panske A; Wood JM
Int J Dermatol; 2008 Jul; 47(7):743-53. PubMed ID: 18613887
[TBL] [Abstract][Full Text] [Related]
5. Estrogens can contribute to hydrogen peroxide generation and quinone-mediated DNA damage in peripheral blood lymphocytes from patients with vitiligo.
Schallreuter KU; Chiuchiarelli G; Cemeli E; Elwary SM; Gillbro JM; Spencer JD; Rokos H; Panske A; Chavan B; Wood JM; Anderson D
J Invest Dermatol; 2006 May; 126(5):1036-42. PubMed ID: 16528352
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen peroxide regulates the cholinergic signal in a concentration dependent manner.
Schallreuter KU; Elwary S
Life Sci; 2007 May; 80(24-25):2221-6. PubMed ID: 17335854
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of oxidative stress in vitiligo.
Schallreuter KU
Skin Pharmacol Appl Skin Physiol; 1999; 12(3):132-8. PubMed ID: 10393521
[TBL] [Abstract][Full Text] [Related]
8. Basic research confirms coexistence of acquired Blaschkolinear Vitiligo and acrofacial Vitiligo.
Schallreuter KU; Krüger C; Rokos H; Hasse S; Zothner C; Panske A
Arch Dermatol Res; 2007 Aug; 299(5-6):225-30. PubMed ID: 17404749
[TBL] [Abstract][Full Text] [Related]
9. Systemic skin whitening/lightening agents: what is the evidence?
Malathi M; Thappa DM
Indian J Dermatol Venereol Leprol; 2013; 79(6):842-6. PubMed ID: 24177629
[No Abstract] [Full Text] [Related]
10. Blunted epidermal L-tryptophan metabolism in vitiligo affects immune response and ROS scavenging by Fenton chemistry, part 1: Epidermal H2O2/ONOO(-)-mediated stress abrogates tryptophan hydroxylase and dopa decarboxylase activities, leading to low serotonin and melatonin levels.
Schallreuter KU; Salem MA; Gibbons NC; Martinez A; Slominski R; Lüdemann J; Rokos H
FASEB J; 2012 Jun; 26(6):2457-70. PubMed ID: 22415302
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase.
Schallreuter KU; Moore J; Wood JM; Beazley WD; Gaze DC; Tobin DJ; Marshall HS; Panske A; Panzig E; Hibberts NA
J Investig Dermatol Symp Proc; 1999 Sep; 4(1):91-6. PubMed ID: 10537016
[TBL] [Abstract][Full Text] [Related]
12. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients.
Schallreuter KU; Wood JM; Lemke KR; Levenig C
Dermatology; 1995; 190(3):223-9. PubMed ID: 7599386
[TBL] [Abstract][Full Text] [Related]
13. Perturbed 6-tetrahydrobiopterin recycling via decreased dihydropteridine reductase in vitiligo: more evidence for H2O2 stress.
Hasse S; Gibbons NC; Rokos H; Marles LK; Schallreuter KU
J Invest Dermatol; 2004 Feb; 122(2):307-13. PubMed ID: 15009710
[TBL] [Abstract][Full Text] [Related]
14. Allergic contact dermatitis to hydroxydecyl ubiquinone (idebenone) following application of anti-ageing cosmetic cream.
Mc Aleer MA; Collins P
Contact Dermatitis; 2008 Sep; 59(3):178-9. PubMed ID: 18759903
[No Abstract] [Full Text] [Related]
15. Accelerating bleaching in vitiligo: balancing benefits versus risks.
Seneschal J; Boniface K; Ezzedine K; Taieb A
Exp Dermatol; 2014 Dec; 23(12):879-80. PubMed ID: 25039467
[TBL] [Abstract][Full Text] [Related]
16. Chloroquine-induced vitiligo-like depigmentation.
Selvaag E
Ann Trop Paediatr; 1997 Mar; 17(1):45-8. PubMed ID: 9176577
[TBL] [Abstract][Full Text] [Related]
17. Chemical-Induced Vitiligo.
Harris JE
Dermatol Clin; 2017 Apr; 35(2):151-161. PubMed ID: 28317525
[TBL] [Abstract][Full Text] [Related]
18. Epidermal H(2)O(2) accumulation alters tetrahydrobiopterin (6BH4) recycling in vitiligo: identification of a general mechanism in regulation of all 6BH4-dependent processes?
Schallreuter KU; Moore J; Wood JM; Beazley WD; Peters EM; Marles LK; Behrens-Williams SC; Dummer R; Blau N; Thöny B
J Invest Dermatol; 2001 Jan; 116(1):167-74. PubMed ID: 11168813
[TBL] [Abstract][Full Text] [Related]
19. Is Bindi-induced depigmentation common in patients predisposed to vitiligo?
Bose SK
J Dermatol; 1994 May; 21(5):370-1. PubMed ID: 8051327
[No Abstract] [Full Text] [Related]
20. A double-blind, randomized trial of 0.05% betamethasone vs. topical catalase/dismutase superoxide in vitiligo.
Sanclemente G; Garcia JJ; Zuleta JJ; Diehl C; Correa C; Falabella R
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1359-64. PubMed ID: 18624857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
